Outcomes 2016 - Baylor Hamilton Heart and Vascular Hospital FY 2016 | Page 71

EXCLUDER – Evaluation of the GORE EXCLUDER Iliac Branch Endoprosthesis for the Treatment of Common Iliac Artery Aneurysms or Aorto-Iliac Aneurysms . Primary Investigator : William Shutze , MD
Experience with Endovascular Aortic Repairs at BUMC . Primary Investigator : William Shutze , MD
Extended Release Exenatide vs . Placebo – A Prospective , double blind , placebo controlled , parallel group , randomized trial of extended release exenatide versus placebo in diabetic patients with type 4 cardiorenal syndrome . Primary Investigator : Peter A . McCullough , MD
Facilitating Patient Reported Outcome Measurement for Key Conditions . Primary Investigator : Peter McCullough , MD
GORE Hybrid Vascular Graft – Evaluation of antiplatelet factor 4 / heparin antibodies in hemodialysis patients implanted with the GORE Hybrid Vascular Graft versus non-heparin bonded synthetic vascular grafts . Primary Investigator : Stephen Hohmann , MD
GREAT – Global Registry for Endovascular Aortic Treatment . Primary Investigator : Dennis Gable , MD
Gross and histological features of mitral valve prolapse . Primary Investigator : William C . Roberts , MD
HeartWare ® Ventricular Assist System ( VAS ) – Prospective , randomized , controlled , un-blinded , multi-center clinical trial to evaluate the HeartWare ® Ventricular Assist System ( VAS ) for Destination Therapy of advanced heart failure . Primary Investigator : Gonzalo Gonzalez-Stawinski , MD
Heart Weight in Autopsy Cases . Primary Investigator : William C . Roberts , MD
HUMANITY – An Assessment of Humacyte ’ s Human Acellular Vessel in Patients Needing Renal Replacement Therapy : A Comparison with ePTFE Grafts as Conduits for Hemodialysis . Primary Investigator : Stephen Hohmann , MD
Impact of Enhanced External Counterpulsation – EECP on Heart Failure Outcomes Following Hospitalization for Acutely Decompensated Heart Failure . Primary Investigator : Peter A . McCullough , MD
Impact of Troponin Testing Across the Baylor Scott and White NTX Region . Primary Investigator : Robert Kowal , MD
Low-Risk TAVR Patients – Transcatheter Aortic Valve Replacement With the Medtronic Transcatheter Aortic Valve Replacement System In Patients at Low Risk for Surgical Aortic Valve Replacement . Primary Investigator : Robert Stoler , MD
Infrageniculate Peripheral Disease Prospective Trial – Comparing laser atherectomy to angioplasty with / without stenting for infrageniculate peripheral disease . Primary Investigator : William Shutze , MD
Instant noodle and cardiometabolic risk factors – Dietary pattern , instant noodle and cardiometabolic risk factors : Primary Investigators : Hyun Shin , MD , Peter A . McCullough , MD
ION Paclitaxel-Eluting Platinum Chrominum Coronary Stent System – A U . S . post-approval study . Primary Investigator : Robert Stoler , MD
IXCELL EXTENSION – A Multicenter , Randomized , Double-Blind , Placebo-Controlled , Parallel Group Study to Evaluate the Efficacy , Safety and Tolerability of Transendocardial Injection of Ixmyelocel-T in Subjects with Heart Failure Due to Ischemia Dilated Cardiomyopathy ( IDCM ). Primary Investigator : Cara East , MD
JOSTENT – Coronary Stent Graft Humanitarian Use Device . Primary Investigator : Robert Stoler , MD
Levo CTS – A double-blind , randomized placebocontrolled study of Levosimendan in Patients with Left Ventricular Systolic Dysfunction undergoing cardiac surgery requiring cardiopulmonary bypass ; LEVO- CTS . Primary Investigators : Daniel Gunn , MD , Cara East , MD
Lixisenatide in Type 2 Diabetes – A randomized , double-blind , placebo-controlled , parallel-group , multicenter study to evaluate cardiovascular outcomes during treatment with lixisenatide in type 2 diabetes patients after an acute coronary syndrome event . Primary Investigator : Cara East , MD
LOWER – Lomitapide Observational Worldwide Evaluation Registry . Primary Investigator : Peter A . McCullough , MD
LVAD and Medical Management in Ambulatory HF Patients – Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients . Primary Investigator : Shelley Hall , MD
Measurement of Functional Capacity Requirements of Farmers : Implications for a Cardiac Rehabilitation Training Program . Primary Investigator : Jenny Adams , PhD
Medtronic CoreValve – Continued Access Study ( Extreme Risk Patients ) – Evolut R , Expanded Use , U . S . Pivotal Trial . Primary Investigator : Robert Stoler , MD
Medtronic Endeavor ® Resolute Zotarolimus Eluting Coronary Stent System – A clinical evaluation of the Medtronic Endeavor ® Resolute Zotarolimus Eluting Coronary Stent System in the treatment of De Novo lesions in native coronary arteries with a reference vessel diameter of 2.25mm to 4.2mm . Primary Investigator : Robert Stoler , MD
Mental Health of Brief-Stay Cardiac Patients – Assessment of the value of a brief intervention and referral to a mental health professional for brief-stay cardiac hospital patients who report feelings of hopelessness and worthlessness . Primary Investigator : Michael Davis , ThM
Micra Transcatheter Pacing System Continued Access Protocol . Primary Investigator : Robert Kowal , MD
Mitral and Aortic Valve Replacement Indications and Results – Indications for and results of combined mitral and aortic valve replacement at BUMC . Primary Investigator : William C . Roberts , MD
Mitral Annular Calcium – Mitral valve replacement because of mitral stenosis due to massive mitral annular calcium . Primary Investigator : William C . Roberts , MD
Mitral Valve Replacement After Failed Mitral Repair – Replacement with ring insertion for pure mitral regurgitation . Primary Investigator : William C . Roberts , MD
Neurocognitive function in destination therapy patients before and after receiving a continuous flow left ventricular assist device . Primary Investigators : Sandra Carey , NP , Shelley Hall , MD
ODYSSEY OLE – Open-Label Extension Study of EFC12492 , R727-CL-1112 , EFC12732 , & LTS11717 Studies to Assess the Long-Term Safety and Efficacy of Alirocumab in Patients with Heterozygous Familial Hypercholesterolemia . Primary Investigator : Cara East , MD
ODYSSEY OUTCOMES – Randomized , Double- Blind , Placebo-Controlled , Parallel-Group Study to Evaluate the Effect of SAR236553 / REGN727 on the Occurence of Cardiovascular Events in Patients Who Have Recently Experienced an Acute Coronary Syndrome . Primary Investigator : Cara East , MD
Pain Relief Associated with Interpleural Tubes – Evaluation of a New Method of Relieving Pain Associated with Interpleural Tubes following Thoracic or Cardiac Surgery . Primary Investigator : Robert F . Hebeler , Jr ., MD
PLATINUM – A prospective , Randomized , Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System ( PROMUS Element™ ) for the Treatment of up to two De Novo Coronary Artery Lesions . Primary Investigator : Robert Stoler , MD
Post-MI Remodeling Prevention Therapy Study . Primary Investigator : Jay Franklin , MD
Pragmatic Trial of Airway Management in Outof-Hospital Cardiac Arrest ( Pragmatic Airway Resuscitation Trial ). Primary Investigator : John Garrett , MD
Prasugrel use in patients receiving bivalirudin in the cardiac cath lab . Primary Investigator : Jeffrey M . Schussler , MD
Preventive Cardiology Registry . Primary Investigator : Peter A . McCullough , MD
PROACT Trial – Clinical trial of the On-X ® Valve using low-dose anticoagulation , or by its informal designation prospective randomized On-X ® Valve Anticoagulation Clinical Trial ( PROACT ). Primary Investigator : Baron L . Hamman , MD
Protocol to conduct a broad range of retrospective data reviews on heart transplants , lung transplants , VAD and cardiology . Primary Investigator : Gonzalo Gonzalez-Stawinski , MD
Pulmonary Vein Reconnection – Pulmonary vein reconnection after cryoballoon pulmonary vein isolation . Primary Investigator : Kevin Wheelan , MD
Pure Aortic Regurgitation – Associated with congenitally malformed bicuspid aortic valve and unassociated with infective endocarditis . Primary Investigator : William C . Roberts , MD
QUARK – A randomized , double-blind , placebo controlled , Phase II study to evaluate efficacy and safety of QPI-1002 for the prevention of acute kidney injury in subjects at high risk for AKI following cardiac surgery . Primary Investigator : Robert F . Hebeler , Jr ., MD
Radial Versus Femoral Artery Approach – Clinical outcomes and metabolomic and damage associated molecular patterns of acute kidney injury in patients undergoing percutaneous coronary intervention via the radial versus femoral artery approach . Primary Investigator : Jeffrey M . Schussler , MD
OUTCOMES 2016
69